Clinical Trial Update: Study of GPX-100 in the Treatment of Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study of GPX-100 for metastatic breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• GPX-100

Snippet

Sponsor: Gem Pharmaceuticals | Conditions: Breast Cancer, Metastasis | Phase 2 | Status: TERMINATED